Lintitript

Alternative names

1 25 dihydroxyvitamin D3 receptor, 25-dihydroxyvitamin D3 receptor, AP-1, Activator protein 1, BXR, CCK A, CCK-A receptor, CCK1-R, CCKAR_HUMAN, CCKR Type A, CCKRA, Cholecystokinin A receptor, Cholecystokinin receptor type A, Cholecystokinin type A receptor, Cholecystokinin-1 receptor, Deubiquitinating enzyme 1, Enhancer Binding Protein AP1, JUN protein, JUNC, JUN_HUMAN, Jun Activation Domain Binding Protein, Jun oncogene, Jun proto oncogene, Member 1, NF-E2-related factor 2, NF2L2_HUMAN, NR1C3, NR1I1, NR1I2_HUMAN, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, Nuclear receptor subfamily 1 group C member 3, Nuclear receptor subfamily 1 group I member 1, Nuclear receptor subfamily 1 group I member 2, ONR 1, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Oncogene JUN, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PPAR-gamma, PPARG2, PPARG_HUMAN, PPP1R163, PRR, Peroxisome proliferator activated receptor gamma 2, Peroxisome proliferator-activated receptor gamma, Pregnane X receptor, Protein phosphatase 1, regulatory subunit 163, Proto-oncogene c-jun, SXR, Steroid and xenobiotic receptor, TRFR_HUMAN, TRH Receptor, TRH-R, Thyroliberin receptor, Thyrotropin-releasing hormone receptor, Transcription factor AP-1, UBP, UBP1_HUMAN, Ubiquitin carboxyl-terminal hydrolase 1, Ubiquitin specific peptidase 1, Ubiquitin specific protease 1, Ubiquitin thioesterase 1, Ubiquitin thiolesterase 1, Ubiquitin-specific-processing protease 1, V jun sarcoma virus 17 oncogene homolog, V jun sarcoma virus 17 oncogene homolog (avian), V-jun avian sarcoma virus 17 oncogene homolog, VDR_HUMAN, Vitamin D (1,25- dihydroxyvitamin D3) receptor, Vitamin D hormone receptor, Vitamin D nuclear receptor variant 1, Vitamin D receptor, Vitamin D3 receptor, cJun, erythroid derived 2, hUBP, like 2, nuclear factor erythroid 2 like 2, p39, pregnane X nuclear receptor variant 2